Piperazine → (3,5-Dibromo-4-hydroxy-phenyl)-(7-trifluoromethyl-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl)-methanone

HRID 1943660ノート

反応式

HRID 1943660 の反応式
[Br:1][C:2]1[CH:3]=[C:4]([C:11]([N:13]2[CH2:18][CH2:17][O:16][C:15]3[N:19]=[CH:20][C:21]([C:23]([F:26])([F:25])[F:24])=[CH:22][C:14]2=3)=[O:12])[CH:5]=[C:6]([Br:10])[C:7]=1[O:8]C.[Br-].[Li+].N1CCNCC1>CN(C)C=O>[Br:1][C:2]1[CH:3]=[C:4]([C:11]([N:13]2[CH2:18][CH2:17][O:16][C:15]3[N:19]=[CH:20][C:21]([C:23]([F:24])([F:26])[F:25])=[CH:22][C:14]2=3)=[O:12])[CH:5]=[C:6]([Br:10])[C:7]=1[OH:8]

参加物

5

反応物 3

HCID 4837PiperazineHCID 82050Lithium BromideHCID 44608067HCID 44608067、化合物

生成物 1

HCID 44608068(3,5-Dibromo-4-hydroxy-phenyl)-(7-trifluoromethyl-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl)-methanone収率 86%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

In a 5 ml flask, (3,5-dibromo-4-methoxy-phenyl)-(7-trifluoromethyl-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl)-methanone (30 mg, 0.061 mmol) was dissolved in N,N-dimethyl formamide (0.3 ml), and then lithium bromide (10 mg, 0.12 mmol) and piperazine (7.8 mg, 0.091 mmol) were added thereto. After stirring for 1 hour, the solvent was removed by evaporation under reduced pressure. The residue was neutralized with water and 1N hydrochloric acid. The resulting solid was filtered to obtain the target compound 22-2 as white solid (25 mg, 86%).

後処理

  1. customthe solvent was removed by evaporation under reduced pressure
  2. filtrationThe resulting solid was filtered

出典と根拠

ORDレコード
ord-83b42c513f2a422c9f1b9d2161306eef
出典データセット
uspto-grants-2013_03
特許番号
US08394792B2

反応ノート

読み込み中…